id,conversation_id,created_at,date,time,timezone,user_id,username,name,place,tweet,language,mentions,urls,photos,replies_count,retweets_count,likes_count,hashtags,cashtags,link,retweet,quote_url,video,thumbnail,near,geo,source,user_rt_id,user_rt,retweet_id,reply_to,retweet_date,translate,trans_src,trans_dest
1125869958074916866,1125869958074916866,2019-05-08 02:38:10 IST,2019-05-08,02:38:10,+0530,943868448047816704,biotechmania,BiotechMania,,ネオアンチゲンを標的としたがんワクチンとT細胞療法を開発する米 ジェノシア Genocea 社 $GNCA のプレゼンテーション資料がネオアンチゲン療法を理解する上で分かりやすい。今年のASCOでワクチン (GEN-009) の第一相試験の初期データを発表予定。  https://t.co/R280RVQ0s8  https://t.co/amvGxjzx9D,ja,[],['https://ir.genocea.com/static-files/bb18673b-aa9f-4839-b567-55ae4b588410'],"['https://pbs.twimg.com/media/D5_kZv4W0AAyuGz.png', 'https://pbs.twimg.com/media/D5_khAsWAAAugrG.png', 'https://pbs.twimg.com/media/D5_klzyWsAARjoi.png', 'https://pbs.twimg.com/media/D5_kp8-W0AIn5c4.jpg']",0,0,18,[],['gnca'],https://twitter.com/BiotechMania/status/1125869958074916866,False,,1,https://pbs.twimg.com/media/D5_kZv4W0AAyuGz.png,,,,,,,[],,,,
1103757907773087745,1103757907773087745,2019-03-08 02:12:46 IST,2019-03-08,02:12:46,+0530,1638909097,thechipclark,Chip Clark,,"As we continue to advance and expand our pipeline, I'm delighted to welcome Diantha to the Genocea team.  #TargetsMatter, but a strong team matters even more, and I'm sure she's making us stronger.  $GNCA",en,[],[],[],1,1,10,['targetsmatter'],['gnca'],https://twitter.com/TheChipClark/status/1103757907773087745,False,https://twitter.com/GenoceaBio/status/1103754378232688644,0,,,,,,,,[],,,,
1060531713791660032,1060531713791660032,2018-11-08 19:27:18 IST,2018-11-08,19:27:18,+0530,1638909097,thechipclark,Chip Clark,,Check out the outstanding Genocea team and our exciting data at #SITC2018!  #targetsmatter $GNCA,en,[],[],[],1,0,10,"['sitc2018', 'targetsmatter']",['gnca'],https://twitter.com/TheChipClark/status/1060531713791660032,False,https://twitter.com/GenoceaBio/status/1060530971068506112,0,,,,,,,,[],,,,
1046924290103422976,1046924290103422976,2018-10-02 06:16:16 IST,2018-10-02,06:16:16,+0530,1638909097,thechipclark,Chip Clark,,"I'm delighted to welcome both Tom and Derek to the Genocea family.  Together, I predict, we'll achieve a lot for patients in the fight against cancer.  $GNCA #targetsmatter",en,[],[],[],3,0,11,['targetsmatter'],['gnca'],https://twitter.com/TheChipClark/status/1046924290103422976,False,https://twitter.com/GenoceaBio/status/1046809558944026624,0,,,,,,,,[],,,,
979100748037402624,979100748037402624,2018-03-29 02:29:43 IST,2018-03-29,02:29:43,+0530,2424331218,genoceabio,Genocea,,Genocea CEO @TheChipClark and other industry leaders participate in Needham &amp; Co's #cancervaccine panel. $GNCA #targetsmatter  https://t.co/2jnwBLdRpZ,en,"[{'screen_name': 'thechipclark', 'name': 'chip clark', 'id': '1638909097'}]",[],['https://pbs.twimg.com/media/DZZ2zp9X4AIw_03.jpg'],0,1,11,"['cancervaccine', 'targetsmatter']",['gnca'],https://twitter.com/GenoceaBio/status/979100748037402624,False,,1,https://pbs.twimg.com/media/DZZ2zp9X4AIw_03.jpg,,,,,,,[],,,,
959453553138991106,959453553138991106,2018-02-02 21:18:47 IST,2018-02-02,21:18:47,+0530,2424331218,genoceabio,Genocea,,Genocea's presentation at @KeystoneSymp #KSsysimm conference yesterday was very well received! Experts agree that “Neoantigen Identification using ATLAS Across Multiple Tumor Types Highlights Limitations of Prediction Algorithms” #targetsmatter $GNCA,en,"[{'screen_name': 'keystonesymp', 'name': 'keystone symposia', 'id': '30064358'}]",[],[],2,3,14,"['kssysimm', 'targetsmatter']",['gnca'],https://twitter.com/GenoceaBio/status/959453553138991106,False,,0,,,,,,,,[],,,,
912420222845489152,912420222845489152,2017-09-26 02:25:07 IST,2017-09-26,02:25:07,+0530,102754598,johncendpts,John Carroll,,"Genocea shelves its lead drug, slashes staff and switches focus to trendy neoantigens $GNCA  https://t.co/OftNlIWKAx",en,[],['https://endpts.com/genocea-shelves-its-lead-drug-slashes-staff-and-switches-focus-to-trendy-neoantigens/'],[],0,2,7,[],['gnca'],https://twitter.com/JohnCendpts/status/912420222845489152,False,,0,,,,,,,,[],,,,
817009319409491968,817009319409491968,2017-01-05 19:36:15 IST,2017-01-05,19:36:15,+0530,185419122,ksbosley,Katrine Bosley,,Congrats to Chip and the whole team at Genocea - important and exciting results in Phase 2b with GEN-003. Well done. $GNCA  https://t.co/19iz23vrgl,en,[],['https://twitter.com/TheChipClark/status/816989723252101120'],[],1,5,18,[],['gnca'],https://twitter.com/ksbosley/status/817009319409491968,False,https://twitter.com/TheChipClark/status/816989723252101120,0,,,,,,,,[],,,,
715519205123043328,715519205123043328,2016-03-31 18:10:46 IST,2016-03-31,18:10:46,+0530,2334614718,openoutcrier,Open Outcrier,,$GNCA (+53.1% pre) Genocea Biosciences Reports Positive 12 Month Efficacy Data From Phase 2 for Genital Herpes    https://t.co/DmOQuEBiRf,en,[],['http://ooc.bz/l/1592'],[],0,3,7,[],['gnca'],https://twitter.com/OpenOutcrier/status/715519205123043328,False,,0,,,,,,,,[],,,,
